<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
  <channel>
    <title>Transkaryotic Therapies Inc — New Patents | PatentBrief</title>
    <link>https://patentbrief.org/company/transkaryotic-therapies-inc</link>
    <description>Plain-English explanations of patents assigned to Transkaryotic Therapies Inc, newest first.</description>
    <language>en-us</language>
    <lastBuildDate>Mon, 15 Jun 2026 06:03:05 GMT</lastBuildDate>
    <atom:link xmlns:atom="http://www.w3.org/2005/Atom" href="https://patentbrief.org/company/transkaryotic-therapies-inc/feed.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>How to Use Modified Cells to Produce Insulin-Regulating Proteins in the Body</title>
      <link>https://patentbrief.org/patent/us/6531124/xolair-omalizumab</link>
      <description>A method for taking a patient&apos;s own cells, modifying them with DNA to produce GLP-1, and putting them back into the body to treat metabolic conditions.</description>
      <pubDate>Tue, 11 Mar 2003 00:00:00 GMT</pubDate>
      <guid isPermaLink="true">https://patentbrief.org/patent/us/6531124/xolair-omalizumab</guid>
    </item>
  </channel>
</rss>
